C

Cajal Neuroscience

58 employees

Cajal Neuroscience is a drug discovery company focused on neurodegenerative disease.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Neuroscience
Therapeutics
Pharmaceutical

Date founded

2020

Funding rounds raised

Total raised

$96M

from 7 investors over 7 rounds

C

Cajal Neuroscience raised $96M on November 29, 2022

Investors: Lux Capital, Bristol-Myers Squibb, UK, Two Sigma Ventures, The Column Group, Dolby Family Ventures and Evotec

C

Cajal Neuroscience raised undisclosed on January 1, 2020

Investors: Lux Capital

FAQ